Fibrinogen human Recruiting Phase 3 Trials for Hypofibrinogenemia, Congenital / Congenital Afibrinogenaemia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02065882Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency